SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-19-064239
Filing Date
2019-11-14
Accepted
2019-11-14 16:25:31
Documents
50
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a19-20458_110q.htm 10-Q 1234562
2 EX-31.1 a19-20458_1ex31d1.htm EX-31.1 10197
3 EX-31.2 a19-20458_1ex31d2.htm EX-31.2 10006
4 EX-32.1 a19-20458_1ex32d1.htm EX-32.1 4599
5 EX-32.2 a19-20458_1ex32d2.htm EX-32.2 4567
  Complete submission text file 0001104659-19-064239.txt   3519166

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT apre-20190930.xml EX-101.INS 462865
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT apre-20190930.xsd EX-101.SCH 31574
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT apre-20190930_cal.xml EX-101.CAL 32594
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT apre-20190930_def.xml EX-101.DEF 106436
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT apre-20190930_lab.xml EX-101.LAB 273291
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT apre-20190930_pre.xml EX-101.PRE 199559
Mailing Address 535 BOYLSTON STREET BOSTON MA 02116
Business Address 535 BOYLSTON STREET BOSTON MA 02116 6095104718
Aprea Therapeutics, Inc. (Filer) CIK: 0001781983 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39069 | Film No.: 191220743
SIC: 2834 Pharmaceutical Preparations